Rebuck, J. A., Eward, W., Slusarczyk, M., Suratt, B., Hebert, J., & Petty, J. (2006). LANSOPRAZOLE ATTENUATES NEUTROPHIL-MEDIATED TISSUE DAMAGE OF LIVER FOLLOWING VISCERAL ISCHEMIA-REPERFUSION INJURY IN MICE. In Critical Care Medicine (Vol. 34, pp. A147–A147). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/00003246-200612002-00510

Rebuck, Jill A., William Eward, Marissa Slusarczyk, Benjamin Suratt, James Hebert, and Joe Petty. “LANSOPRAZOLE ATTENUATES NEUTROPHIL-MEDIATED TISSUE DAMAGE OF LIVER FOLLOWING VISCERAL ISCHEMIA-REPERFUSION INJURY IN MICE.” In Critical Care Medicine, 34:A147–A147. Ovid Technologies (Wolters Kluwer Health), 2006. https://doi.org/10.1097/00003246-200612002-00510.

Rebuck JA, Eward W, Slusarczyk M, Suratt B, Hebert J, Petty J. LANSOPRAZOLE ATTENUATES NEUTROPHIL-MEDIATED TISSUE DAMAGE OF LIVER FOLLOWING VISCERAL ISCHEMIA-REPERFUSION INJURY IN MICE. In: Critical Care Medicine. Ovid Technologies (Wolters Kluwer Health); 2006. p. A147–A147.

Rebuck, Jill A., et al. “LANSOPRAZOLE ATTENUATES NEUTROPHIL-MEDIATED TISSUE DAMAGE OF LIVER FOLLOWING VISCERAL ISCHEMIA-REPERFUSION INJURY IN MICE.” Critical Care Medicine, vol. 34, Ovid Technologies (Wolters Kluwer Health), 2006, pp. A147–A147. Crossref, doi:10.1097/00003246-200612002-00510.

Rebuck JA, Eward W, Slusarczyk M, Suratt B, Hebert J, Petty J. LANSOPRAZOLE ATTENUATES NEUTROPHIL-MEDIATED TISSUE DAMAGE OF LIVER FOLLOWING VISCERAL ISCHEMIA-REPERFUSION INJURY IN MICE. Critical Care Medicine. Ovid Technologies (Wolters Kluwer Health); 2006. p. A147–A147.